Shukra Pharmaceuticals fixes record date for Stock Split
08 - Mar - 2025 12:00 | 23 days ago
Shukra Pharmaceuticals has fixed 21 March 2025 as the record date to ascertain the eligibility of Shareholders for the purpose of sub-division / split of the Equity Shares of the comp-any such that every 1(one) Equity Share having nominal/face value of Rs. 10/- [Rupees Ten 0niyJ each be sub-divided into 10 [Ten) Equity shares having nominal/face value of Rs. 1/- (Rupees one 0nly) each.
Shukra Pharmaceuticals standalone net profit declines 66.45% in the December 2024 quarter
15 - Feb - 2025 12:00 | 44 days ago
Net profit of Shukra Pharmaceuticals declined 66.45% to Rs 3.16 crore in the quarter ended December 2024 as against Rs 9.42 crore during the previous quarter ended December 2023. Sales declined 43.99% to Rs 10.58 crore in the quarter ended December 2024 as against Rs 18.89 crore during the previous quarter ended December 2023.
Shukra Pharmaceuticals standalone net profit declines 66.45% in the December 2024 quarter
15 - Feb - 2025 12:00 | 44 days ago
Net profit of Shukra Pharmaceuticals declined 66.45% to Rs 3.16 crore in the quarter ended December 2024 as against Rs 9.42 crore during the previous quarter ended December 2023. Sales declined 43.99% to Rs 10.58 crore in the quarter ended December 2024 as against Rs 18.89 crore during the previous quarter ended December 2023.
Shukra Pharmaceuticals fixes record date for Stock Split
08 - Mar - 2025 12:00 | 23 days ago
Shukra Pharmaceuticals has fixed 21 March 2025 as the record date to ascertain the eligibility of Shareholders for the purpose of sub-division / split of the Equity Shares of the comp-any such that every 1(one) Equity Share having nominal/face value of Rs. 10/- [Rupees Ten 0niyJ each be sub-divided into 10 [Ten) Equity shares having nominal/face value of Rs. 1/- (Rupees one 0nly) each.
Shukra Pharmaceuticals standalone net profit declines 66.45% in the December 2024 quarter
15 - Feb - 2025 12:00 | 44 days ago
Net profit of Shukra Pharmaceuticals declined 66.45% to Rs 3.16 crore in the quarter ended December 2024 as against Rs 9.42 crore during the previous quarter ended December 2023. Sales declined 43.99% to Rs 10.58 crore in the quarter ended December 2024 as against Rs 18.89 crore during the previous quarter ended December 2023.
Shukra Pharmaceuticals fixes record date for Stock Split
08 - Mar - 2025 12:00 | 23 days ago
Shukra Pharmaceuticals has fixed 21 March 2025 as the record date to ascertain the eligibility of Shareholders for the purpose of sub-division / split of the Equity Shares of the comp-any such that every 1(one) Equity Share having nominal/face value of Rs. 10/- [Rupees Ten 0niyJ each be sub-divided into 10 [Ten) Equity shares having nominal/face value of Rs. 1/- (Rupees one 0nly) each.
Shukra Pharmaceuticals standalone net profit declines 66.45% in the December 2024 quarter
15 - Feb - 2025 12:00 | 44 days ago
Net profit of Shukra Pharmaceuticals declined 66.45% to Rs 3.16 crore in the quarter ended December 2024 as against Rs 9.42 crore during the previous quarter ended December 2023. Sales declined 43.99% to Rs 10.58 crore in the quarter ended December 2024 as against Rs 18.89 crore during the previous quarter ended December 2023.
Shukra Pharmaceuticals standalone net profit declines 66.45% in the December 2024 quarter
15 - Feb - 2025 12:00 | 44 days ago
Net profit of Shukra Pharmaceuticals declined 66.45% to Rs 3.16 crore in the quarter ended December 2024 as against Rs 9.42 crore during the previous quarter ended December 2023. Sales declined 43.99% to Rs 10.58 crore in the quarter ended December 2024 as against Rs 18.89 crore during the previous quarter ended December 2023.
